How does angiotensin AT2 receptor activation help neuronal differentiation and improve neuronal pathological situations?

Frontiers in Endocrinology

Volumn 3, Issue DEC, 2012, Pages

  Guimond, Marie Odile ^a   Gallo Payet, Nicole ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Angiotensin; AT2 receptor; Brain; Cognitive functions; Differentiation; Neurodegenerative disorders; Regeneration; Signaling

Indexed keywords

EID: 84874446135     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00164     Document Type: Review

References (173)

1. Abadir, P. M., Carey, R. M., and Siragy, H.M. (2003). AngiotensinAT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice. Hypertension 42, 600-604.
2. Abadir, P. M., Periasamy, A., Carey, R. M., and Siragy, H. M. (2006). Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension 48, 316-322.
3. AbdAlla, S., Lother, H., el Missiry, A., Langer, A., Sergeev, P., el Fara-mawy, Y., et al. (2009). Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. J. Biol. Chem. 284, 6554-6565.
4. Ali, Q., and Hussain, T. (2012). AT(2) receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats. Hypertens. Res. 35, 654-660.
5. Alvarez, S. E., Seguin, L. R., Villarreal, R. S., Nahmias, C., and Ciuffo, G. M. (2008). Involvement of c-Src tyrosine kinase in SHP-1 phosphatase activation by Ang II AT2 receptors in rat fet al tissues. J. Cell. Biochem. 105, 703-711.
6. Arganaraz, G. A., Konno, A. C., Per-osa, S. R., Santiago, J. F., Boim, M. A., Vidotti, D. B., et al. (2008). The renin-angiotensin system is upregu-lated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis. Epilepsia 49,1348-1357.
7. Baranov, D., and Armstead, W. M. (2005). Nitric oxide contributes to AT2 but not AT1 angiotensin II receptor-mediated vasodilatation of porcine pial arteries and arterioles. Eur. I Pharmacol. 525, 112-116.
8. Basille, M., Cartier, D., Vaudry, D., Lihrmann, I., Fournier, A., Freger, P., et al. (2006). Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development. J. Comp. Neurol. 496, 468-478.
9. Beaudry, H.,Gendron, L., Guimond, M. O., Payet, M. D., and Gallo-Payet, N. (2006). Involvement of protein kinase C alpha (PKC alpha) in the early action of angiotensin II type 2 (AT2) effects on neu-rite outgrowth in NG108-15 cells: AT2-receptor inhibits PKC alpha and p21ras activity. Endocrinology 147, 4263-4272.
10. Bedecs, K., Elbaz, N., Sutren, M., Masson, M., Susini, C., Strosberg, A. D., et al. (1997). Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem. J. 325,449-454.
11. Benson, S. C., Pershadsingh, H. A., Ho, C. I., Chittiboyina, A., Desai, P., Pravenec, M., et al. (2004). Identification of telmis-artan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 43, 993-1002.
12. Boissonneault, V., Filali, M., Lessard, M., Relton, J., Wong, G., and Rivest, S. (2009). Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Brain 132, 1078-1092.
13. Bottari, S. P., King, I. N., Reich-lin, S., Dahlstroem, I., Lydon, N., and de Gasparo, M. (1992a). The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of par-ticulate guanylate cyclase. Biochem. Biophys. Res. Commun. 183,206-211.
14. Bottari, S. P., Obermuller, N., Bogdal, Y., Zahs, K. R., and Deschepper, C. F. (1992b). Characterization and distribution of angiotensin II binding sites in fet al and neonatal astrocytes from different rat brain regions. Brain Res. 585,372-376.
15. Breault, L., Lehoux, J. G., and Gallo-Payet, N. (1996). The angiotensin AT2 receptor is present in the human fet al adrenal gland throughout the second trimester of gestation. J. Clin. Endocrinol Metab. 81, 3914-3922.
16. Brechler, V., Reichlin, S., De Gas-paro, M., and Bottari, S. P. (1994). Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism. Recept. Channels 2, 89-98.
17. Buisson, B., Bottari, S. P., de Gasparo, M., Gallo-Payet, N., and Payet, M. D. (1992). The angiotensin AT2 receptor modulates T-type calcium current in non-differentiated NG108-15 cells. FEBS Lett. 309, 161-164.
18. Buisson, B., Laflamme, L., Bottari, S. P., de Gasparo, M., Gallo-Payet, N., and Payet, M. D. (1995). A G protein is involved in the angiotensin AT2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells. J. Biol. Chem. 270, 1670-1674.
19. Caballero, R., Gomez, R., Moreno, I., Nunez, L., Gonzalez, T., Arias, C., et al. (2004). Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current. Cardiovasc. Res. 62, 86-95.
20. Calo, L. A., Schiavo, S., Davis, P. A., Pagnin, E., Mormino, P., D'Angelo, A., et al. (2010). Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeac-tivity: implications for hypertension. I Hypertens. 28,111-118.
21. Carey, R. M., and Padia, S. H. (2008). Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure. Trends Endocrinol Metab. 19,84-87.
22. Chaki, S., and Inagami, T. (1993). New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis. Mol. Phar macol. 43, 603-608.
23. Cote, E, Do, T. H., Laflamme, L., Gallo, J. M., and Gallo-Payet, N. (1999). Activation of the AT(2) receptor of angiotensin II induces neu-rite outgrowth and cell migration in microexplant cultures of the cerebellum. J. Biol. Chem. 274, 31686-31692.
24. Coté, F., Laflamme, L., Payet, M. D., and Gallo-Payet, N. (1998). Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells. Endocr. Res. 24,403-407.
25. Cui, T., Nakagami, H., Iwai, M., Takeda, Y., Shiuchi, T., Daviet, L., et al. (2001). Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fet al vascular smooth muscle cell. Cardiovasc. Res. 49, 863-871.
26. Cui, T. X., Nakagami, H., Nahmias, C., Shiuchi, T., Takeda-Matsubara, Y., Li, J. M., et al. (2002). Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells. Mol. Endocrinol. 16, 2113-2123.
27. de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., and Unger, T. (2000). International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52, 415-472.
28. de Godoy, M. A., de Oliveira, A. M., and Rattan, S. (2004). Angiotensin II-induced relaxation of anococcygeus smooth muscle via desensitization of AT1 receptor, and activation of AT2 receptor associated with nitric-oxide synthase pathway. J. Pharmacol. Exp. Ther. 311,394-401.
29. de la Torre, J. C. (2004). Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. LancetNeurol. 3, 184-190.
30. De Paolis, P., Porcellini, A., Savoia, C., Lombardi, A., Gigante, B., Frati, G., et al. (2002). Functional crosstalk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts. J. Hypertens. 20, 693-699.
31. Dehmelt, L., and Halpain, S. (2004). Actin and microtubules in neurite initiation: are MAPs the missing link? J. Neurobiol. 58,18-33.
32. Dehmelt, L., Smart, E M., Ozer, R. S., and Halpain, S. (2003). The role of microtubule-associated protein 2c in the reorganization of microtubules and lamellipodia during neurite initiation. J. Neurosci. 23, 9479-94790.
33. Di Benedetto, M., Bieche, I., Deshayes, E, Vacher, S., Nouet, S., Collura, V., et al. (2006). Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene 380,127-136.
34. Dupont,A. G.,andBrouwers,S. (2010). Brain angiotensin peptides regulate sympathetic tone and blood pressure. J. Hypertens. 28, 1599-1610.
35. Elbaz, N., Bedecs, K., Masson, M., Sutren, M., Strosberg, A. D., and Nahmias, C. (2000). Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor. Mol. Endocrinol. 14, 795-804.
36. Feng, Y. H., Sun, Y., and Douglas, J. G. (2002). Gbeta gamma -independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1. Proc. Natl. Acad. Sci. U.S.A. 99, 12049-12054.
37. Fischer, T. A., Singh, K., O'Hara, D. S., Kaye, D. M., and Kelly, R. A. (1998). Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes. Am. J. Physiol. 275, H906-H916.
38. Fuenzalida, K. M., Aguilera, M. C., Piderit, D. G., Ramos, P. C., Contador, D., Quinones, V., et al. (2005). Per-oxisome proliferator-activated receptor gamma is a novel target of the nerve growth factor signaling pathway in PC 12 cells. J. Biol. Chem. 280, 9604-9609.
39. Gallinat, S., Csikos, T., Meffert, S., Herdegen, T., Stoll, M., and Unger, T. (1997). The angiotensin AT2 receptor down-regulates neurofilament M in PC12W cells. Neurosci. Lett. 227, 29-32.
40. Gallinat, S., Yu, M., Dorst, A., Unger, T., and Herdegen, T. (1998). Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves. Brain Res. Mol. Brain Res. 57, 111-122.
41. Gallo, G., and Letourneau, P. C. (2004). Regulation of growth cone actin filaments by guidance cues. J. Neurobiol. 58, 92-102.
42. Gallo-Payet, N., Guimond, M.-O., Bilodeau, L., Wallinder, C., Alter-man, M., and Hallberg, A. (2011). Angiotensin II, a neuropeptide at the frontier between endocrinology and neuroscience: is there a link between the angiotensin II type 2 receptor (AT2R) and Alzheimer's disease? Front. Endocrinol. 2:17. doi: 10.3389/fendo.2011.00017
43. Gallo-Payet, N., Shum, M., Baillargeon, J.-P., Langlois, M.-F., Alterman, M., Hallberg, A., et al. (2012). AT2 receptor agonists: exploiting the beneficial arm of Ang II signaling. Curr. Hypertens. Rev. 8, 47-59.
44. Gao, J., Zhang, H., Le, K. D., Chao, J., and Gao, L. (2011). Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious rats. Am. I Hypertens. 24, 724-730.
45. Gao, L., and Zucker, I. H. (2011). AT2 receptor signaling and sympathetic regulation. Curr. Opin. Pharmacol. 11, 124-130.
46. Gendron, L., Cote, E, Payet, M. D., and Gallo-Payet, N. (2002). Nitric oxide and cyclic GMP are involved in angiotensin II AT(2) receptor effects on neurite outgrowth in NG108-15 cells. Neuroendocrinology 75, 70-81.
47. Gendron, L., Laflamme, L., Rivard, N., Asselin, C., Payet, M. D., and Gallo-Payet, N. (1999). Signals from the AT2 (angiotensin type 2) receptor of angiotensin II inhibit p2 1ras and activate MAPK (mitogen-activated protein kinase) to induce morphological neuronal differentiation in NG108-15 cells. Mol. Endocrinol. 13, 1615-1626.
48. Gendron, L., Payet, M. D., and Gallo-Payet, N. (2003). The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: from observations to mechanisms. J. Mol. Endocrinol. 31,359-372.
49. Gillespie, W., Tyagi, N., and Tyagi, S. C. (2011). Role of PPARgamma, a nuclear hormone receptor in neuro-protection. Indian J. Biochem. Bio-phys. 48, 73-81.
50. Gohlke, P., Pees, C., and Unger, T. (1998). AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 31, 349-355.
51. Gong, C. X., Lidsky, T., Wegiel, J., Zuck, L., Grundke-Iqbal, I., and Iqbal, K. (2000). Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J. Biol. Chem. 275,5535-5544.
52. Gong, C. X., Singh, T. J., Grundke-Iqbal, I., and Iqbal, K. (1993). Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 61,921-927.
53. Gordon-Weeks, P. R. (1991). Control of microtubule assembly in growth cones.J. Cell Sci. Suppl. 15,45-49.
54. Grady, E. F., Sechi, L. A., Griffin, C. A., Schambelan, M., and Kalinyak, J. E. (1991). Expression of AT2 receptors in the developing rat fetus. J. Clin. Invest. 88,921-933.
55. + ATPase in primary cortical cultures. Neurosci. Res. 50, 299-306.
56. Grammatopoulos, T. N., Morris, K., Bachar, C., Moore, S., Andres, R., and Weyhenmeyer, J. A. (2004b). Angiotensin II attenuates chemical hypoxia-induced caspase-3 activation in primary cortical neuronal cultures. Brain Res. Bull. 62, 297-303.
57. Grammatopoulos, T. N., Jones, S. M., Ahmadi, E A., Hoover, B. R., Snell, L. D., Skoch, J., et al. (2007). Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra. Mol. Neu-rodegener. 2, 1-17.
58. Grant, S. G., O'Dell, T. J., Karl, K. A., Stein, P. L., Soriano, P., and Kandel, E. R. (1992). Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258, 1903-1910.
59. Guimond, M. O., Roberge, C., and Gallo-Payet, N. (2010). Fyn is involved in angiotensin II type 2 receptor-induced neurite outgrowth, but not in p42/p44mapk in NG108-15 cells. Mol. Cell Neurosci. 45, 201-212.
60. Hanger, D. P., Anderton, B. H., and Noble, W. (2009). Tau phospho-rylation: the therapeutic challenge for neurodegenerative disease. Trends Mol.Med. 15, 112-119.
61. Hansen, J., Servant, G., Baranski, T., Fujita, T., Iiri, T., and Sheikh, S. (2000). Functional reconstitution of the angiotensin II type 2 receptor and G(i) activation. Circ. Res. 87, 753-759.
62. Hein, L., Barsh, G. S., Pratt, R. E., Dzau, V. J., and Kobilka, B. K. (1995). Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377, 744-747.
63. Hein, L., Meinel, L., Pratt, R. E., Dzau, V. J., and Kobilka, B. K. (1997). Intra-cellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol. 11, 1266-1277.
64. Hernandez, F., and Avila, J. (2008). The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease. FEBS Lett. 582, 3848-3854.
65. Hernandez, F., Gomez de Barreda, E., Fuster-Matanzo, A., Lucas, J. J., and Avila, J. (2009). GSK3: a possible link between beta amyloid peptide and tau protein. Exp. Neurol. 223, 322-325.
66. Hiroi, Y., Hiroi, J., Kudoh, S., Yazaki, Y., Nagai, R., and Komuro, I. (2001). Two distinct mechanisms of angiotensin II-induced negative regulation of the mitogen-activated protein kinases in cultured cardiac myocytes. Hypertens. Res. 24, 385-394.
67. Hobara, N., Goda, M., Yoshida, N., Takatori, S., Kitamura, Y., Mio, M., and Kawasaki, H. (2007). Angiotensin II type 2 receptors facilitate reinnervation of phenol-lesioned vascular calcitonin gene-related peptide-containing nerves in rat mesenteric arteries. Neuroscience 150,730-741.
68. Horiuchi, M., Hayashida, W., Kambe, T., Yamada, T., and Dzau, V. J. (1997). Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apopto-sis. J. Biol.Chem. 272, 19022-19026.
69. Horiuchi, M., Iwanami, J.,andMogi, M. (2012). Regulation of angiotensin II receptors beyond the classical pathway. Clin. Sci. (Lond) 123, 193-203.
70. Horiuchi, M., and Mogi, M. (2011). Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage. Br. J. Pharmacol. 163,1122-1130.
71. Horiuchi, M., Mogi, M., and Iwai, M. (2010). The angiotensin II type 2 receptor in the brain. J. Renin Angiotensin Aldosterone Syst. 11, 1-6.
72. Huang, X. C., Richards, E. M., and Sumners, C. (1995). Angiotensin II type 2 receptor-mediated stimulation of protein phosphatase 2A in rat hypothalamic/brainstem neuronal cocultures. J. Neurochem. 65, 2131-2137.
73. Huang, X. C., Richards, E. M., and Sumners, C. (1996a). Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J. Biol. Chem. 271,15635-15641.
74. Huang, X. C., Sumners, C., and Richards, E. M. (1996b). Angiotensin II stimulates protein phosphatase 2A activity in cultured neuronal cells via type 2 receptors in a pertussis toxin sensitive fashion. Adv. Exp. Med. Biol. 396,209-215.
75. Hunyady, L., Bor, M., Balla, T., and Catt, K. J. (1994). Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internal -ization of the AT1 angiotensin receptor. J. Biol.Chem. 269, 31378-37382.
76. Hunyady, L., and Catt, K. J. (2006). Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol. 20, 953-970.
77. Iadecola, C. (2004). Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5, 347-360.
78. Iadecola, C., Park, L., and Capone, C. (2009). Threats to the mind: aging, amyloid, and hypertension. Stroke 40, S40-S44.
79. Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., et al. (1995). Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377, 748-750.
80. Iwai, M., Liu, H. W., Chen, R., Ide, A., Okamoto, S., Hata, R., et al. (2004). Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 110, 843-848.
81. Iwai, M., Tomono, Y., Inaba, S., Kanno, H., Senba, I., Mogi, M., and Horiuchi, M. (2009). AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice. Am. J. Hypertens. 22, 784-791.
82. Iwanami, J., Mogi, M., Tsukuda, K., Min, L. J., Sakata, A., Jing, F., et al. (2010). Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice. J. Hypertens. 28, 1730-1737.
83. Jing, F., Mogi, M., Sakata, A., Iwanami, J., Tsukuda, K., Ohshima, K., et al. (2012). Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J. Cereb. Blood Flow Metab. 32, 248-255.
84. Kalia, L. V., Gingrich, J. R., and Salter, M. W. (2004). Src in synaptic transmission and plasticity. Oncogene 23, 8007-8016.
85. Kalil, K., and Dent, E. W. (2005). Touch and go: guidance cues signal to the growth cone cytoskeleton. Curr. Opin. Neurobiol. 15,521-526.
86. + currents involves an inhibitory GTP binding protein. Am. J. Physiol. 267, C1389-C1397.
87. Karamyan, V. T., and Speth, R. C. (2007). Identification of a novel non-AT1, non-AT2 angiotensin binding site in the rat brain. Brain Res. 1143, 83-91.
88. Kilian, P., Campbell, S., Bilodeau, L., Guimond, M. O., Roberge, C., Gallo-Payet, N., et al. (2008). Angiotensin II type 2 receptor stimulation increases the rate of NG108-15 cell migration via actin depolymer-ization. Endocrinology 149, 2923-2933.
89. Kojima, N., Wang, J., Mansuy, I. M., Grant, S. G., Mayford, M., and Kandel, E. R. (1997). Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene. Proc. Natl. Acad. Sci. U.S.A. 94,4761-4765.
90. LaFerla, E M., Green, K. N., and Oddo, S. (2007). Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 8, 499-509.
91. Laflamme, L., Gasparo, M., Gallo, J. M., Payet, M. D., and Gallo-Payet, N. (1996). Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J. Biol. Chem. 271,22729-22735.
92. Lee, G., Newman, S. T., Gard, D. L., Band, H., and Panchamoorthy, G. (1998). Tau interacts with src-family non-receptor tyrosine kinases. J. Cell Sci. 111(Pt. 21), 3167-3177.
93. Lee, G., Thangavel, R., Sharma, V. M., Litersky, J. M., Bhaskar, K. Fang, S. M., et al. (2004). Phosphoryla-tion of tau by fyn: implications for Alzheimer's disease. J. Neurosci. 24, 2304-2312.
94. Lenkei, Z., Palkovits, M., Corvol, P., and Llorens-Cortes, C. (1996). Distribution of angiotensin II type-2 receptor (AT2) mRNA expression in the adult rat brain. J Comp. Neurol. 373,322-339.
95. Lenkei, Z., Palkovits, M., Corvol, P., and Llorens-Cortes, C. (1997). Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front. Neuroendocrinol. 18:383-439. doi: 10.1006/frne.1997.0155
96. Li, J., Culman, J., Hortnagl, H., Zhao, Y., Gerova, N., Timm, M., et al. (2005). Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEBJ. 19, 617-619.
97. Li, J. M., Mogi, M., Tsukuda, K., Tomochika, H., Iwanami, J., Min, L. J., et al. (2007). Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol. Endocrinol. 21, 499-511.
98. Li, X., Lerea, K. M., Li, J., and Olson, S. C. (2004). Src kinase mediates angiotensin II-dependent increase in pulmonary endothelial nitric oxide synthase. Am. J. Respir. Cell Mol. Biol. 31,365-372.
99. Lucius, R., Gallinat, S., Rosenstiel, P., Herdegen, T., Sievers, J., and Unger, T. (1998). The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J. Exp. Med. 188, 661-670.
100. Matavelli, L. C., Huang, J., and Siragy, H. M. (2011). Angiotensin AT receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 57, 308-313.
101. Matsubara, H., Shibasaki, Y., Oki-gaki, M., Mori, Y., Masaki, H., Kosaki, A. et al. (2001). Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor. Biochem. Biophys. Res. Commun. 282,1085-1091.
102. Matsuura, T., Kumagai, H., Onimaru, H., Kawai, A., Iigaya, K., Onami, T., et al. (2005). Electrophysiologi-cal properties of rostral ventrolateral medulla neurons in angiotensin II 1a receptor knockout mice. Hypertension 46, 349-354.
103. Maul, B., von Bohlen und Halbach, O., Becker, A., Sterner-Kock, A., Voigt, J. P., Siems, W. E., et al. (2008). Impaired spatial memory and altered dendritic spine morphology in angiotensin II type 2 receptor-deficient mice. J. Mol. Med. 86, 563-571.
104. McCarthy, C. A., Vinh, A., Call-away, J. K., and Widdop, R. E. (2009). Angiotensin AT2 Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of Stroke. Stroke 40,1482-1489.
105. Meffert, S., Stoll, M., Steckelings, U. M., Bottari, S. P., and Unger, T. (1996). The angiotensin IIAT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol. 122, 59-67.
106. Merabet, L., de Gasparo, M., and Casanova, C. (1997). Dose-dependent inhibitory effects of angiotensin II on visual responses of the rat superior colliculus: AT1 and AT2 receptor contributions. Neuropeptides 31, 469-481.
107. Millan, M. A., Jacobowitz, D. M., Aguil-era, G., and Catt, K. J. (1991). Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development. Proc. Natl. Acad. Sci. U.S.A.88, 11440-11444.
108. Miura, S., Karnik, S. S., and Saku, K. (2005). Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J. Biol.Chem. 280,18237-18244.
109. Mogi, M., and Horiuchi, M., (2012). Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenera-tive diseases. Geriatr. Gerontol Int. doi: 10.1111/j.1447 [Epub ahead of print].
110. Mogi, M.,Li, J. M., Iwanami, J., Min, L. J., Tsukuda, K., Iwai, M., et al. (2006). Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension 48, 141-148.
111. Mogi, M., Li, J. M., Tsukuda, K., Iwanami, J., Min, L. J., Sakata, A., et al. (2008). Telmisartan prevented cognitive decline partly due to PPAR-gamma activation. Biochem. Biophys. Res. Commun. 375, 446-449.
112. Mucke, L. (2009). Neuroscience: Alzheimer's disease. Nature 461, 895- 897.
113. Muller, D., Greenland, K. J., Speth, R. C., and Middendorff, R. (2010). Neuronal differentiation of NG108-15 cells has impact on nitric oxide-and membrane (natriuretic peptide receptor-A) cyclic GMP-generating proteins. Mol. Cell Endocrinol. 320, 118-127.
114. Nahmias, C., Cazaubon, S. M., Briend-Sutren, M. M., Lazard, D., Vil-lageois, P., and Strosberg, A. D. (1995). Angiotensin II AT2 receptors are functionally coupled to protein tyrosine dephosphorylation in N1E-115 neuroblastoma cells. Biochem. J. 306(Pt. 1), 87-92.
115. Nelson, P. T., Braak, H., and Markesbery, W. R. (2009). Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J. Neuropathol. Exp. Neurol. 68, 1-14.
116. Nouet, S., Amzallag, N., Li, J. M., Louis, S., Seitz, I., Cui, T. X., et al. (2004). Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J. Biol. Chem. 279, 28989-28997.
117. Nouet, S., and Nahmias, C. (2000). Signal transduction from the angiotensin II AT2 receptor. Trends Endocrinol. Metab. 11,1-6.
118. Nuyt, A. M., Lenkei, Z., Palkovits, M., Corvol, P., and Llorens-Cortes, C., (1999). Ontogeny of angiotensin II type 2 receptor mRNA expression in fet al and neonatal rat brain. J. Comp. Neurol. 407, 193-206.
119. Ohnishi, H., Murata, Y., Okazawa, H., and Matozaki, T. (2011). Src family kinases: modulators of neurotrans-mitter receptor function and behavior. Trends Neurosci. 34, 629-637.
120. Okuyama, S., Sakagawa, T., Chaki, S., Imagawa, Y., Ichiki, T., and Inagami, T. (1999). Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor. Brain Res. 821, 150-159.
121. Olson, S., Oeckler, R., Li, X., Du, L., Traganos, F., Zhao, X., et al. (2004). Angiotensin II stimulates nitric oxide pro duction in pulmonary artery endothelium via the type 2 receptor. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L559-L568.
122. Ozawa, Y., Suzuki, Y., Murakami, K., and Miyazaki, H. (1996). The angiotensin II type 2 receptor primarily inhibits cell growth via pertussis toxin-sensitive G proteins. Biochem. Biophys. Res. Commun. 228, 328-333.
123. Phillips, M. I. and de Oliveira, E. M. (2008). Brain renin angiotensin in disease. J. Mol. Med. 86, 715-722.
124. Plouffe, B., Guimond, M. O., Beaudry, H., and Gallo-Payet, N. (2006). Role of tyrosine kinase receptors in angiotensin IIAT2 receptor signaling: involvement in neurite outgrowth and in p42/p44mapk activation in NG108-15 cells. Endocrinology 147, 4646-4654.
125. Porrello, E. R., Delbridge, L. M., and Thomas, W. G. (2009). The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor. Front. Biosci. 14:958-972. doi: 10.2741/3289
126. Prast, H., and Philippu, A. (2001). Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64, 51-68.
127. Rajagopal, R., Chen, Z. Y., Lee, F. S., and Chao, M. V. (2004). Transactiva-tion of Trkneurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J. Neurosci. 24, 6650-6658.
128. Reinecke, K., Lucius, R., Reinecke, A., Rickert, U., Herdegen, T., and Unger, T. (2003). Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. FASEB J. 17, 2094-2096.
129. Rodrigues-Ferreira, S., Di Tommaso, A., Dimitrov, A., Cazaubon, S., Gruel, N., Colasson, H., et al. (2009). 8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis. PLoS ONE 4:e7239. doi: 10.1371/jour-nal.pone.0007239
130. Rodrigues-Ferreira, S., and Nahmias, C. (2010). An ATIPical family of angiotensin II AT2 receptor-interacting proteins. Trends Endocrinol. Metab. 21, 684-690.
131. Rompe, F., Artuc, M., Hallberg, A., Alterman, M., Stroder, K., Thone-Reineke, C., et al. (2010). Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension 55, 924-931.
132. Saito, S., Hirata, Y., Emori, T., Imai, T., and Marumo, F. (1996). Angiotensin II activates endothelial constitutive nitric oxide synthase via AT1 receptors. Hypertens. Res. 19, 201-206.
133. Sanchez, C., Diaz-Nido, J., and Avila, J. (2000). Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskele-ton function. Prog. Neurobiol. 61, 133-168.
134. Schupp, M., Janke, J., Clasen, R., Unger, T., and Kintscher, U. (2004). Angiotensin type 1 receptor block-ers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 109, 2054-2057.
135. Schutz, S., Le Moullec, J. M., Corvol, P., and Gasc, J. M. (1996). Early expression of all the components of the renin-angiotensin-system in human development. Am. J. Pathol. 149, 2067-2079.
136. Searles, C. D., and Harrison, D. G. (1999). The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: lessons learned from transgenic mice. J. Clin. Invest. 104,1013-1014.
137. Seguin, L. R., Villarreal, R. S., and Ciuffo, G. M. (2012). AT2 receptors recruit c-Src, SHP-1 and FAK upon activation byAng II in PND15 rat hindbrain. Neurochem. Int. 60, 199-207.
138. Seidel, K., Kirsch, S., Lucht, K., Zaade, D., Reinemund, J., Schmitz, J., et al. (2011). The promyelocytic leukemia zinc finger (PLZF) protein exerts neu-roprotective effects in neuronal cells and is dysregulated in experimental stroke. Brain Pathol. 21, 31-43.
139. Senbonmatsu, T., Saito, T., Landon, E. J., Watanabe, O., Price, E. Jr., Roberts, R. L., et al. (2003). A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBOJ. 22, 6471-6482.
140. Seyedi, N., Xu, X., Nasjletti, A., and Hintze, T. H. (1995). Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 26, 164-170.
141. Shibasaki, Y., Matsubara, H., Nozawa, Y., Mori, Y., Masaki, H., Kosaki, A., Tsut-sumi, Y., et al. (2001). Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactiva-tion by increasing association of SHP-Ityrosine phosphatase. Hypertension 38,367-372.
142. Siragy, H. M. (2010). The angiotensin II type 2 receptor and the kidney. J. Renin Angiotensin Aldosterone Syst. 11,33-36.
143. Siragy, H. M., and Carey, R. M. (1996). The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guano-sine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J. Clin. Invest. 97, 1978-1982.
144. Siragy, H. M., and Carey, R. M. (2010). Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am. J. Nephrol. 31,541-550.
145. Steckelings, U. M., Kaschina, E., and Unger, T. (2005). The AT2 receptor-a matter of love and hate. Peptides 26, 1401-1409.
146. Steckelings, U. M., Rompe, F., Kaschina, E., Namsolleck, P., Grzesiak, A., Funke-Kaiser, H., et al. (2010). The past, present and future of angiotensin II type 2 receptor stimulation. J. Renin. Angiotensin. Aldos-terone. Syst. 11,67-73.
147. Stroth, U., Blume, A., Mielke, K., and Unger T. (2000). Angiotensin AT(2) receptor stimulates ERK1 and ERK2 in quiescent but inhibits ERK in NGF-stimulated PC12W cells. Brain Res. Mol. Brain Res. 78,175-180.
148. Stroth, U., Meffert, S., Gallinat, S., and Unger, T. (1998). Angiotensin II and NGF differentially influence micro-tubule proteins in PC12W cells: role of the AT2 receptor. Brain Res. Mol. Brain Res. 53,187-195.
149. Theus, M., Wei, L., Francis, K., and Ping Yu, S. (2006). Critical roles of Src family tyrosine kinases in excitatory neuronal differentiation of cultured embryonic stem cells. Exp. Cell Res. 312,3096-3107.
150. Thorup, C., Kornfeld, M., Winaver, J. M., Goligorsky, M. S., and Moore, L. C. (1998). Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries. Pflugers Arch. 435, 432-434.
151. Tsukuda, K., Mogi, M., Iwanami, J., Min, L. J., Sakata, A., Jing, E, et al. (2009). Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation. Hypertension 54, 782-787.
152. Tsutsumi, K., and Saavedra, J. M. (1991). Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am. J. Physiol. 261, R209-R216.
153. Tsuzuki, S., Eguchi, S., and Inagami, T. (1996a). Inhibition of cell proliferation and activation of protein tyrosine phosphatase mediated by angiotensin II type 2 (AT2) receptor in R3T3 cells. Biochem. Biophys. Res. Commun. 228, 825-830.
154. Tsuzuki, S., Matoba, T., Eguchi, S., and Inagami, T. (1996b). Angiotensin II type 2 receptor inhibits cell proliferation and activates tyrosine phosphatase. Hypertension 28, 916-918.
155. Verdonk, K., Danser, A. H., and van Esch, J.H. (2012). AngiotensinII type 2 receptor agonists: where should they be applied? Expert Opin. Investig. Drugs 21, 501-513.
156. Vetter, M. L., and Bishop, J. M. (1995). Beta PDGF receptor mutants defective for mitogenesis promote neurite outgrowth in PC 12 cells. Curr. Biol. 5, 168-178.
157. Volpe, M., Musumeci, B., De Paolis, P., Savoia, C., and Morganti, A. (2003). Angiotensin IIAT2 receptor subtype: an uprising frontier in cardiovascular disease?J. Hypertens. 21, 1429-1443.
158. Wan, Y., Wallinder, C., Plouffe, B., Beaudry, H., Mahalingam, A. K., Wu, X., et al. (2004). Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J. Med. Chem. 47, 5995-6008.
159. Wang, J. Z., Grundke-Iqbal, I., and Iqbal, K. (2007). Kinases and phos-phatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur. I Neurosci. 25, 59-68.
160. Washida, K., Ihara, M., Nishio, K., Fujita, Y., Maki, T., Yamada, M., et al. (2010). Nonhypoten-sive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion. Stroke 41, 1798-1806.
161. Widdop, R. E., Jones, E. S., Hannan, R. E., and Gaspari, T. A. (2003). Angiotensin AT2 receptors: cardiovascular hope or hype? Br. J. Pharmacol. 140, 809-924.
162. Wiemer, G., Scholkens, B. A., Wagner, A., Heitsch, H., and Linz, W (1993). The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts. J. Hypertens. Suppl. 11, S234-S235.
163. Wright, J. W., and Harding, J. W (2011). Brain renin-angiotensin-a new look at an old system. Prog. Neurobiol. 95, 49-67.
164. Wright, J.W., and Harding, J.W (2012). The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases. Pflugers Arch. doi: 10.1234/12345678 [Epub ahead of print].
165. Wruck, C. J., Funke-Kaiser, H., Pufe, T., Kusserow, H., Menk, M., Schefe, J. H., et al. (2005). Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler. Thromb. Vasc. Biol. 25, 57-64.
166. Xiong, H., and Marshall, K. C. (1994). Angiotensin II depresses glutamate depolarizations and excitatory post-synaptic potentials in locus coeruleus through angiotensin II subtype 2 receptors. Neuroscience 62, 163-175.
167. Yamada, T., Horiuchi, M., and Dzau, V. J. (1996). Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. U.S.A. 93,156-160.
168. Yu, L., Zheng, M., Wang, W., Rozanski, G. J., Zucker, I. H., and Gao, L. (2010). Developmental changes in AT1 and AT2 receptor-protein expression in rats. J. Renin Angiotensin Aldosterone Syst. 11,214-221.
169. Yu, X. M., Askalan, R., Keil, G. J. II, and Salter, M. W. (1997). NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science 275, 674-678.
170. Zhang, J., and Pratt, R. E. (1996). The AT2 receptor selectively associates with Gialpha2 and Gialpha3 in the rat fetus. J. Biol. Chem. 271, 15026-15033.
171. Zhao, Y., Biermann, T., Luther, C., Unger, T., Culman, J., and Gohlke, P. (2003). Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC 12W cells. J. Neurochem. 85, 759-767.
172. Zhao, Y., Foryst-Ludwig, A., Bruem-mer, D., Culman, J., Bader, M., Unger, T., et al. (2005). Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation. J. Neurochem. 94, 1395- 1401.
173. Zlokovic, B. V. (2005). Neurovascu-lar mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 28, 202-208.